Gylcerol-3-phosphate shuttle and its function in intermediary metabolism of hamster brown-adipose tissue.
1. Brown adipose tissue of the hamster possesses high specific activities of soluble, cytoplasmic NAD-linked, as well as mitochondrial flavin-coupled, glycerol-3-phosphate dehydrogenases. The ratio of the two enzyme activities is high (close to 1), when compared with other tissues of the hamster. 2. In the presence of rotenone, NADH is oxidised very poorly by homogenates of brown adipose tissue. A high rate of oxidation is obtained upon further addition of dihydroxyacetone phosphate, which itself is negligible oxidised. When followed fluorimetrically glycerol 3-phosphate can also be observed to induce NADH oxidation, but only after a significant lag time. Similar results are obtained with isolated mitochondria plus high-speed supernatant. With high-speed supernatant alone, only dihydroxyacetone phosphate has any effect, whereas with isolated mitochondria neither dihydroxyacetone phosphate nor glycerol 3-phosphate induce any NADH disappearance. 3. Respiration induced by NADH plus dihydroxyacetone phosphate in homogenates equals 56% of the respiration induced by glycerol 3-phosphate alone. 4. Respiration induced by NADH plus dihydroxyacetone phosphate, as well as that induced by glycerol 3-phosphate, is inhibited by the same concentrations of inhibitors as are required for inhibition of the mitochondrial dehydrogenase i.e. EDTA, long-chain unsaturated fatty acids, long-chain fatty acyl CoA esters. 5. In isolated brown adipocytes in the presence of rotenone, norepinephrine significantly inhibits respiration induced by glycerol 3-phosphate. 6. The results obtained are discussed with respect to the role of glycerol 3-phosphate as an electron sink for cytosolic reducing equivalents to maintain a low level of extramitochondrial NADH. A means of maintaining a level of glycerol 3-phosphate adequate for triglyceride synthesis is also considered.
D002001:Adipose Tissue, Brown / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism* / Q000648:ultrastructure; D000818:Animals; D003065:Coenzyme A / Q000494:pharmacology; D006224:Cricetinae; D003593:Cytoplasm / Q000201:enzymology / Q000378:metabolism; D004099:Dihydroxyacetone Phosphate / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D005993:Glycerolphosphate Dehydrogenase / Q000032:analysis; D005994:Glycerophosphates / Q000378:metabolism* / Q000494:pharmacology; D008928:Mitochondria / Q000201:enzymology / Q000378:metabolism; D009243:NAD / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D009829:Oleic Acids / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D010169:Palmitic Acids / Q000494:pharmacology; D012402:Rotenone / Q000494:pharmacology
D005994:Glycerophosphates; D009829:Oleic Acids; D010169:Palmitic Acids; D012402:Rotenone; D009243:NAD; D004099:Dihydroxyacetone Phosphate; D004492:Edetic Acid; D005993:Glycerolphosphate Dehydrogenase; D003065:Coenzyme A; D009638:Norepinephrine